Internal Medicine, Hematology & Oncology · Hartford, CT
NPI
1689600629
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
85 Retreat Ave
Hartford, CT, 06106
Phone (860) 249-6291
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
912 services
Medicare patients, 2024
261
Average age 76
Drug cost, 2024
$6.1M
959 prescriptions
Company payments, 2025
$28.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark E Dailey was code 99214 (office e&m - established), 379 times for 163 patients. In total Mark E Dailey billed 912 services in 11 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 379 | 163 | $74.96 | $28K |
| 99215 Office E&M - Established | Office | 152 | 58 | $115.80 | $18K |
| 99214 Office E&M - Established | Facility | 122 | 60 | $70.79 | $8,636 |
| 99215 Office E&M - Established | Facility | 102 | 30 | $107.82 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 16 | $62.68 | $2,820 |
| 99205 Office E&M - New | Office | 21 | 21 | $138.62 | $2,911 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 16 | $13.55 | $230 |
| 99205 Office E&M - New | Facility | 16 | 16 | $134.41 | $2,150 |
| 99213 Office E&M - Established | Office | 11 | 11 | $36.59 | $402 |
By year: 2022 $71K for 875 services; 2023 $81K for 908 services; 2024 $78K for 912 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark E Dailey prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 111 prescriptions and refills. In total Mark E Dailey wrote 959 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 111 | 120 | Under 11 | $2.1M |
| Revlimid Lenalidomide | 64 | 64 | Under 11 | $1.1M |
| Venclexta Venetoclax | 57 | 57 | 11 | $458K |
| Acyclovir Generic | 47 | 117 | 16 | $874 |
| Imatinib Mesylate Generic | 39 | 39 | Under 11 | $71K |
| Eliquis Apixaban | 35 | 68 | 11 | $39K |
| Warfarin Sodium Generic | 34 | 67 | Under 11 | $68.82 |
| Calquence Acalabrutinib Maleate | 34 | 34 | Under 11 | $476K |
| Hydroxyurea Generic | 32 | 74 | Under 11 | $499 |
| Oxycodone Hcl Generic | 30 | 30 | Under 11 | $146 |
| Lorazepam Generic | 23 | 23 | Under 11 | $40.59 |
| Anastrozole Generic | 21 | 63 | Under 11 | $162 |
| Dexamethasone Generic | 20 | 49 | 12 | $348 |
| Jakafi Ruxolitinib Phosphate | 20 | 20 | Under 11 | $343K |
| Jaypirca Pirtobrutinib | 18 | 18 | Under 11 | $156K |
Brand drugs: - claims; generic drugs: 517 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark E Dailey $28.11 ($28.11 in general payments such as food, travel and fees) from 1 company. The largest payer was Celgene Corporation with $28.11.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 1 | $28.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.